Abhirise 20mg Research Overview
Abhirise 20mg is a phosphodiesterase type 5 (PDE5) inhibitor developed by HAB Pharmaceuticals specifically for in-vitro research applications. This compound belongs to the tadalafil citrate class of selective PDE5 inhibitors, offering researchers a precisely formulated tool for investigating vascular smooth muscle relaxation mechanisms and nitric oxide-cGMP signalling pathways in laboratory environments. The 20mg formulation provides standardised dosing for controlled experimental protocols examining vasodilation responses in isolated tissue preparations.
Research scientists investigating cardiovascular pharmacology will find Abhirise particularly valuable when examining the molecular interactions between PDE5 enzymes and cyclic guanosine monophosphate degradation pathways. Stroid UK Shop maintains rigorous quality standards to ensure each tablet delivers consistent active compound concentrations for reproducible experimental outcomes in vascular biology research.
Laboratory Applications
Abhirise serves multiple research applications in cardiovascular and smooth muscle physiology studies. Research teams examine its selective inhibition properties when investigating corpus cavernosum tissue responses, pulmonary arterial smooth muscle relaxation, and endothelial function in isolated organ preparations. The compound’s extended half-life characteristics make it particularly suitable for prolonged experimental protocols requiring sustained PDE5 inhibition.
Comparative studies often evaluate Abhirise alongside other tadalafil citrate compounds to analyse dose-response relationships and selectivity profiles across different PDE enzyme subtypes. Research applications extend to investigating nitric oxide pathway modulation in various tissue types, including studies examining vascular remodelling processes and smooth muscle contractility mechanisms. Scientists also utilise this compound when evaluating potential drug interactions with nitrate compounds and alpha-blocker medications in controlled laboratory settings.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Tadalafil Citrate |
| Strength | 20mg per tablet |
| Manufacturer | HAB Pharmaceuticals |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Research Classification | PDE5 Inhibitor |
Quality assurance protocols ensure each batch meets pharmaceutical-grade standards suitable for research applications. Storage recommendations include maintaining tablets in original packaging away from moisture and direct sunlight to preserve compound stability throughout experimental programmes.
Research Compliance Statement
Abhirise 20mg is supplied exclusively for in-vitro research purposes and is not intended for human consumption or therapeutic use. Research institutions should establish appropriate laboratory protocols when handling this compound and ensure compliance with local regulations governing research chemical usage. SARMs research compounds and other investigational substances require similar handling procedures within accredited research facilities.
This product joins our comprehensive catalogue of research chemicals alongside peptide compounds and other pharmaceutical-grade materials designed specifically for laboratory investigations. All research applications should be conducted by qualified personnel within appropriate institutional frameworks following established safety protocols and ethical guidelines for laboratory research involving vasoactive compounds.
